V+ Funds 1 Overview
V+ Funds 1 General Information
Description
V+ Funds 1 was a venture capital fund managed by Venture Plus. The fund was located in Cologne, Germany. The fund aimed to invest in life sciences, TMT, pharmaceuticals and biotechnology companies.
Contact Information
Fund Manager's Location
- Wupper place 7
- 51061 Cologne
- Germany
V+ Funds 1 Investments (4)
V+ Funds 1 has made a total of 4 investments. Its most recent deal was a with Axiogenesis. The deal was made on 23-Mar-2011.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Axiogenesis | 23-Mar-2011 | Biotechnology | Startup | |||
| Proximus | 11-Nov-2009 | Multimedia and Design Software | Startup | |||
| BMDSys Production | 01-Jun-2007 | Early Stage VC | Diagnostic Equipment | Startup | ||
| 4DForce | 07-Feb-2007 | Early Stage VC | Entertainment Software | Generating Revenue |
V+ Funds 1 Investment Strategy
Investments by Industry
Investments by Deal Type
V+ Funds 1 Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
V+ Funds 1 Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
V+ Funds 1 FAQs
-
What is V+ Funds 1?
V+ Funds 1 was a venture capital fund managed by Venture Plus.
-
Who manages V+ Funds 1?
V+ Funds 1 is managed by Venture Plus.
-
Where is V+ Funds 1 domiciled?
V+ Funds 1 is domiciled in Germany.
-
What type of fund is V+ Funds 1?
The fund type of V+ Funds 1 is Venture.
-
What is the status of V+ Funds 1?
V+ Funds 1 is liquidated.
-
What has V+ Funds 1 invested in?
V+ Funds 1 has made numerous investments in companies like Axiogenesis, Proximus, and BMDSys Production within the Biotechnology, Multimedia and Design Software, and Diagnostic Equipment industries.
-
What has V+ Funds 1 invested in recently?
V+ Funds 1's latest investment was on 23-Mar-2011 in Axiogenesis, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
